Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $2,660 | 2 | 63.0% |
| Food and Beverage | $1,376 | 27 | 32.6% |
| Education | $186.76 | 3 | 4.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Mallinckrodt Hospital Products Inc. | $1,860 | 1 | $0 (2023) |
| PFIZER INC. | $816.22 | 2 | $0 (2024) |
| Paragonix Technologies, Inc. | $599.44 | 5 | $0 (2024) |
| Astellas Pharma US Inc | $202.14 | 4 | $0 (2021) |
| Abbott Laboratories | $179.47 | 1 | $0 (2023) |
| Actelion Pharmaceuticals US, Inc. | $171.79 | 2 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $106.92 | 5 | $0 (2020) |
| United Therapeutics Corporation | $68.87 | 3 | $0 (2024) |
| Medtronic, Inc. | $62.48 | 1 | $0 (2023) |
| Eurofins Viracor, Inc. | $32.20 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,572 | 8 | PFIZER INC. ($800.00) |
| 2023 | $2,123 | 4 | Mallinckrodt Hospital Products Inc. ($1,860) |
| 2022 | $51.00 | 2 | Actelion Pharmaceuticals US, Inc. ($27.28) |
| 2021 | $186.76 | 3 | Astellas Pharma US Inc ($164.98) |
| 2020 | $22.21 | 1 | Boehringer Ingelheim Pharmaceuticals, Inc. ($22.21) |
| 2019 | $51.24 | 2 | Eurofins Viracor, Inc. ($32.20) |
| 2018 | $101.17 | 6 | Boehringer Ingelheim Pharmaceuticals, Inc. ($36.69) |
| 2017 | $115.56 | 6 | Boehringer Ingelheim Pharmaceuticals, Inc. ($48.02) |
All Payment Transactions
32 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/29/2024 | United Therapeutics Corporation | TYVASO (Drug) | Food and Beverage | In-kind items and services | $28.05 | General |
| Category: Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lung Disease | ||||||
| 10/08/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Food and Beverage | In-kind items and services | $144.51 | General |
| Category: Cardiology | ||||||
| 08/19/2024 | Paragonix Technologies, Inc. | SherpaPak (Device), LiverGuard, LungGuard | Food and Beverage | In-kind items and services | $218.30 | General |
| Category: Cardiology | ||||||
| 05/01/2024 | Paragonix Technologies, Inc. | SherpaPak (Device), LiverGuard, LungGuard | Food and Beverage | In-kind items and services | $221.10 | General |
| Category: Cardiology | ||||||
| 04/11/2024 | Paragonix Technologies, Inc. | — | Food and Beverage | In-kind items and services | $142.92 | General |
| 04/11/2024 | Paragonix Technologies, Inc. | — | Food and Beverage | In-kind items and services | $15.26 | General |
| 04/11/2024 | Paragonix Technologies, Inc. | — | Food and Beverage | In-kind items and services | $1.86 | General |
| 02/15/2024 | PFIZER INC. | PAXLOVID (Drug) | Consulting Fee | Cash or cash equivalent | $800.00 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 04/28/2023 | Abbott Laboratories | MITRACLIP (Device) | Food and Beverage | In-kind items and services | $179.47 | General |
| Category: Vascular | ||||||
| 03/12/2023 | Medtronic, Inc. | GI GENIUS (Device) | Food and Beverage | In-kind items and services | $62.48 | General |
| Category: Gastrointestinal AI | ||||||
| 02/22/2023 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $20.99 | General |
| 01/18/2023 | Mallinckrodt Hospital Products Inc. | CELLEX (Device) | Consulting Fee | Cash or cash equivalent | $1,860.00 | General |
| Category: CRITICAL CARE | ||||||
| 03/31/2022 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Food and Beverage | In-kind items and services | $27.28 | General |
| Category: Cardiology | ||||||
| 03/04/2022 | AtriCure, Inc. | ATRICURE CRYOICE CRYOABLATION SYSTEM (CRYO2) (Device) | Food and Beverage | In-kind items and services | $23.72 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/02/2021 | Astellas Pharma US Inc | — | Education | In-kind items and services | $99.99 | General |
| 12/02/2021 | Astellas Pharma US Inc | — | Education | In-kind items and services | $64.99 | General |
| 07/29/2021 | United Therapeutics Corporation | TYVASO (Drug) | Education | In-kind items and services | $21.78 | General |
| Category: PAH | ||||||
| 08/20/2020 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $22.21 | General |
| Category: RESPIRATORY | ||||||
| 02/28/2019 | Eurofins Viracor, Inc. | — | Food and Beverage | Cash or cash equivalent | $32.20 | General |
| 01/22/2019 | United Therapeutics Corporation | ORENITRAM (Drug) | Food and Beverage | In-kind items and services | $19.04 | General |
| Category: PAH | ||||||
| 08/30/2018 | AbbVie, Inc. | Creon (Drug) | Food and Beverage | In-kind items and services | $15.75 | General |
| Category: Endocrinology | ||||||
| 08/16/2018 | La Jolla Pharmaceutical Company | GIAPREZA (Drug) | Food and Beverage | In-kind items and services | $16.13 | General |
| Category: GIAPREZA | ||||||
| 07/19/2018 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $18.57 | General |
| 06/13/2018 | AbbVie, Inc. | Creon (Drug) | Food and Beverage | In-kind items and services | $14.47 | General |
| Category: Endocrinology | ||||||
| 01/23/2018 | PORTOLA PHARMACEUTICALS, INC. | BEVYXXA (Drug) | Food and Beverage | Cash or cash equivalent | $18.13 | General |
| Category: CARDIOLOGY/HEMATOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 559 | 959 | $295,664 | $90,032 |
| 2022 | 11 | 573 | 960 | $295,592 | $87,634 |
| 2021 | 12 | 629 | 1,137 | $371,273 | $107,838 |
| 2020 | 12 | 707 | 1,180 | $379,559 | $101,907 |
All Medicare Procedures & Services
46 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 189 | 303 | $122,109 | $41,410 | 33.9% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 52 | 195 | $56,160 | $18,192 | 32.4% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 20 | 54 | $33,210 | $9,100 | 27.4% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 150 | 253 | $22,410 | $6,442 | 28.7% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 36 | 39 | $11,544 | $3,526 | 30.5% |
| 31628 | Biopsy of lobe of lung using an endoscope, 1 lobe | Facility | 2023 | 21 | 21 | $10,416 | $2,872 | 27.6% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 20 | 20 | $11,200 | $2,742 | 24.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 22 | 25 | $7,500 | $2,390 | 31.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 13 | 13 | $7,449 | $1,826 | 24.5% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 11 | 11 | $4,191 | $1,130 | 27.0% |
| 31624 | Irrigation and suction of lung airways to obtain cells using an endoscope | Facility | 2023 | 25 | 25 | $9,475 | $402.37 | 4.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 179 | 269 | $108,407 | $36,694 | 33.8% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 61 | 211 | $60,768 | $16,874 | 27.8% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 23 | 59 | $36,285 | $10,022 | 27.6% |
| 71046 | X-ray of chest, 2 views | Office | 2022 | 153 | 242 | $21,240 | $5,973 | 28.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 38 | 53 | $15,900 | $4,870 | 30.6% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 15 | 16 | $8,960 | $2,488 | 27.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 14 | 14 | $8,022 | $2,442 | 30.4% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 28 | 29 | $8,584 | $2,385 | 27.8% |
| 31628 | Biopsy of lobe of lung using an endoscope, 1 lobe | Facility | 2022 | 16 | 17 | $8,432 | $2,360 | 28.0% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 21 | 22 | $8,382 | $2,322 | 27.7% |
| 31624 | Irrigation and suction of lung airways to obtain cells using an endoscope | Facility | 2022 | 25 | 28 | $10,612 | $1,203 | 11.3% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 188 | 288 | $116,760 | $38,302 | 32.8% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 64 | 268 | $78,312 | $21,743 | 27.8% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 31 | 108 | $67,908 | $18,590 | 27.4% |
About Dr. Sofya Tokman, MD
Dr. Sofya Tokman, MD is a Critical Care Medicine healthcare provider based in Phoenix, Arizona. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/15/2009. The National Provider Identifier (NPI) number assigned to this provider is 1396070983.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sofya Tokman, MD has received a total of $4,223 in payments from pharmaceutical and medical device companies, with $1,572 received in 2024. These payments were reported across 32 transactions from 16 companies. The most common payment nature is "Consulting Fee" ($2,660).
As a Medicare-enrolled provider, Tokman has provided services to 2,468 Medicare beneficiaries, totaling 4,236 services with total Medicare billing of $387,411. Data is available for 4 years (2020–2023), covering 46 distinct procedure/service records.
Practice Information
- Specialty Critical Care Medicine
- Other Specialties Pulmonary Disease
- Location Phoenix, AZ
- Active Since 10/15/2009
- Last Updated 11/29/2018
- Taxonomy Code 207RC0200X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1396070983
Products in Payments
- CELLEX (Device) $1,860
- PAXLOVID (Drug) $800.00
- SherpaPak (Device) $439.40
- MITRACLIP (Device) $179.47
- OPSUMIT (Drug) $144.51
- OFEV (Drug) $63.04
- GI GENIUS (Device) $62.48
- TYVASO (Drug) $49.83
- Cresemba (Drug) $37.16
- Creon (Drug) $30.22
- UPTRAVI (Drug) $27.28
- ATRICURE CRYOICE CRYOABLATION SYSTEM (CRYO2) (Device) $23.72
- ORENITRAM (Drug) $19.04
- BEVYXXA (Drug) $18.13
- CHANTIX (Drug) $16.22
- GIAPREZA (Drug) $16.13
- Adempas (Drug) $14.16
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Critical Care Medicine Doctors in Phoenix
Mr. Rajat Walia, Md, MD
Critical Care Medicine — Payments: $855,124
Dr. Abid Khokar, Md, MD
Critical Care Medicine — Payments: $156,969
Dr. Jagruti Patel, Md, MD
Critical Care Medicine — Payments: $134,469
Naomi Habib, Md, MD
Critical Care Medicine — Payments: $124,020
Ali Saeed, Md, MD
Critical Care Medicine — Payments: $95,529
Heather Przybyl, Dnp, Rn, Accns-Ag, DNP, RN, ACCNS-AG
Critical Care Medicine — Payments: $49,436